Adage Capital Partners’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-390,100
| Closed | -$7.5M | – | 777 |
|
|
2019
Q3 | $7.5M | Sell |
390,100
-1,310,000
| -77% | -$25.2M | 0.02% | 576 |
|
|
2019
Q2 | $50.2M | Sell |
1,700,100
-555,900
| -25% | -$16.4M | 0.13% | 205 |
|
|
2019
Q1 | $107M | Sell |
2,256,000
-890,411
| -28% | -$42.3M | 0.27% | 94 |
|
|
2018
Q4 | $114M | Buy |
3,146,411
+496,411
| +19% | +$17.9M | 0.31% | 82 |
|
|
2018
Q3 | $163M | Sell |
2,650,000
-150,000
| -5% | -$9.23M | 0.36% | 63 |
|
|
2018
Q2 | $189M | Sell |
2,800,000
-271,635
| -9% | -$18.3M | 0.43% | 52 |
|
|
2018
Q1 | $167M | Buy |
3,071,635
+460,000
| +18% | +$25M | 0.39% | 65 |
|
|
2017
Q4 | $156M | Sell |
2,611,635
-463,365
| -15% | -$27.7M | 0.35% | 71 |
|
|
2017
Q3 | $149M | Sell |
3,075,000
-375,000
| -11% | -$18.2M | 0.36% | 68 |
|
|
2017
Q2 | $181M | Buy |
3,450,000
+1,350,000
| +64% | +$70.9M | 0.44% | 45 |
|
|
2017
Q1 | $95.2M | Sell |
2,100,000
-100,000
| -5% | -$4.54M | 0.24% | 112 |
|
|
2016
Q4 | $83.3M | Buy |
2,200,000
+549,216
| +33% | +$20.8M | 0.23% | 119 |
|
|
2016
Q3 | $62.3M | Sell |
1,650,784
-449,216
| -21% | -$17M | 0.17% | 153 |
|
|
2016
Q2 | $37M | Buy |
2,100,000
+75,000
| +4% | +$1.32M | 0.1% | 244 |
|
|
2016
Q1 | $24.6M | Buy |
2,025,000
+400,000
| +25% | +$4.86M | 0.07% | 320 |
|
|
2015
Q4 | $39.6M | Buy |
1,625,000
+125,000
| +8% | +$3.04M | 0.1% | 233 |
|
|
2015
Q3 | $26.6M | Buy |
+1,500,000
| New | +$26.6M | 0.07% | 318 |
|